WST (West Pharmaceutical Services) Forward P/E Multiple

WST (West Pharma) - company brandmark

West Pharmaceutical Services is implementing ESG principles by creating recyclable packaging and reducing energy consumption. The company's consensus forward P/E clearly demonstrates the business's profitability, with 40.30 representing the latest metric reading. Stability is ensured by outsourcing standardized production to external partners, while high customer loyalty is based on the FDA certification of unique drug delivery systems.

Price to Future Earnings Ratio: West Pharmaceutical Services, Inc. (WST) for 07/04/2022 - 11/17/2026

Comprehensive metric breakdowns and analytics for westpharma.com (WST)

Fundamental valuation:West Pharma WST
Product sample of West Pharmaceutical Services

The pricing power of West Pharmaceutical Services (WST) in the certified closure segment directly impacts the dynamics of the business's forward P/E. This indicator expresses the ratio of the current market share price to the projected earnings per share. The metric allows for an assessment of how much an investor is willing to pay for a unit of future income. Stable price indexation ensures earnings predictability, smoothing the volatility of the indicator. The rising trend confirms market confidence in the company's expansion.

Analysis of competing companies

Future Price to Earnings Intuitive Surgical Inc (ISRG)|DHR (Danaher Corp) - Future Price to Earnings Multiple|Forward P/E Multiple BDX (bd.com)|Market Cap to Projected Earnings steris.com (STE)|BAX - Future Price to Earnings|Market Cap to Projected Earnings Masimo Corp MASI|Stevanato Group S.p.A. (STVN) - Future Price to Earnings|TFX - Market Cap to Projected Earnings|Future Price to Earnings merit.com|Envista (NVST) - Market Cap to Projected Earnings|Projected Price to Earnings ICUI (ICU Medical, Inc.)|Market Cap to Future Earnings Ratio XRAY|Future Price to Earnings LeMaitre LMAT|Future Price to Earnings Multiple ATRC|STAA: Projected Price to Earnings|NAGE - Forward P/E Multiple|ZimVie Inc (ZIMV) - Future Price to Earnings|Projected Price to Earnings AngioDynamics|CERS (cerus.com) - Forward P/E Multiple|Projected Price to Earnings Ratio Teknova Inc TKNO|Future Price to Earnings Monogram Orthopedics (MGRM)|Sharps Tech - Price to Future Earnings Ratio|InfuSystem Holdings, Inc. - Projected Price to Earnings|Market Cap to Future Earnings Ratio UTMD (Utah Medical Products Inc.)|KRMD - Future Price to Earnings|Market Cap to Projected Earnings Nyxoah S.A NYXH|microbotmedical.com (MBOT) - Future Price to Earnings|Price to Expected Earnings Ratio PDEX (pro-dex.com)|ZTEK (Zentek Corp) - Forward P/E Multiple|Future Price to Earnings ELUT|Future Price to Earnings Milestone Scientific Corp (MLSS)|NEXGEL, Inc - Price to Future Earnings Ratio|Forward P/E Multiple RVP (Retractable Technologies Inc.)|Harvard Bioscience, Inc. - Future Price to Earnings|FEMY - Future Price to Earnings|MHUA - Forward P/E Multiple|POAI: Forward P/E Multiple|Price to Future Earnings Ratio CJMB|Projected Price to Earnings ATRI|Projected Price to Earnings Ratio NeuroMetrix NURO